Hyun Ju Jeong, Hyeji Park, Steffi Kar Kei Yuen, Christine Joy Castillo, Seung-June Oh, Sung Yong Cho
{"title":"Comparison of surgical outcomes of endoscopic enucleation of the prostate using different energies.","authors":"Hyun Ju Jeong, Hyeji Park, Steffi Kar Kei Yuen, Christine Joy Castillo, Seung-June Oh, Sung Yong Cho","doi":"10.1177/17562872241303457","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>This study evaluates surgical outcomes in benign prostatic hyperplasia (BPH) patients undergoing transurethral enucleation using various holmium laser (HoLEP) settings and/or bipolar devices (BipoLEP).</p><p><strong>Design: </strong>This study was retrospective.</p><p><strong>Methods: </strong>We retrospectively analyzed 158 BPH patients treated surgically, categorized by method: BipoLEP (<i>n</i> = 28), HoLEP with short pulse (HoLEP-SP, <i>n</i> = 26), HoLEP with long pulse and low energy (HoLEP-LP/LE, <i>n</i> = 29), HoLEP with long pulse and high energy (HoLEP-LP/HE, <i>n</i> = 26), HoLEP using Moses technology (HoLEP-Mo, <i>n</i> = 19), and a combination of HoLEP and BipoLEP (HoLEP-mix, <i>n</i> = 30). We assessed enucleation, morcellation, coagulation, and overall operation efficiency, along with complications at immediate, 2-week, and 3-month postoperative intervals.</p><p><strong>Results: </strong>The HoLEP-LP/LE group exhibited the highest overall operation efficiency (<i>p</i> < 0.05). The BipoLEP and HoLEP-SP groups had lower enucleation efficiency (<i>p</i> < 0.05). HoLEP-LP/LE and BipoLEP showed superior coagulation efficiency (<i>p</i> < 0.05). Excluding hard nodule cases, the HoLEP-mix group had reduced morcellation efficiency compared to HoLEP-LP/LE (<i>p</i> < 0.05). Complication rates did not significantly differ between groups (<i>p</i> > 0.05).</p><p><strong>Conclusion: </strong>The HoLEP-LP/LE procedure demonstrated superior performance in enucleation, morcellation, coagulation, and overall operation efficiency. Complication rates were comparable across all groups. BipoLEP, while less efficient in enucleation than some HoLEP settings, proved effective and safe. In addition, the Moses technology may offer enhanced bleeding control.</p>","PeriodicalId":23010,"journal":{"name":"Therapeutic Advances in Urology","volume":"16 ","pages":"17562872241303457"},"PeriodicalIF":2.6000,"publicationDate":"2024-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11605735/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic Advances in Urology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/17562872241303457","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: This study evaluates surgical outcomes in benign prostatic hyperplasia (BPH) patients undergoing transurethral enucleation using various holmium laser (HoLEP) settings and/or bipolar devices (BipoLEP).
Design: This study was retrospective.
Methods: We retrospectively analyzed 158 BPH patients treated surgically, categorized by method: BipoLEP (n = 28), HoLEP with short pulse (HoLEP-SP, n = 26), HoLEP with long pulse and low energy (HoLEP-LP/LE, n = 29), HoLEP with long pulse and high energy (HoLEP-LP/HE, n = 26), HoLEP using Moses technology (HoLEP-Mo, n = 19), and a combination of HoLEP and BipoLEP (HoLEP-mix, n = 30). We assessed enucleation, morcellation, coagulation, and overall operation efficiency, along with complications at immediate, 2-week, and 3-month postoperative intervals.
Results: The HoLEP-LP/LE group exhibited the highest overall operation efficiency (p < 0.05). The BipoLEP and HoLEP-SP groups had lower enucleation efficiency (p < 0.05). HoLEP-LP/LE and BipoLEP showed superior coagulation efficiency (p < 0.05). Excluding hard nodule cases, the HoLEP-mix group had reduced morcellation efficiency compared to HoLEP-LP/LE (p < 0.05). Complication rates did not significantly differ between groups (p > 0.05).
Conclusion: The HoLEP-LP/LE procedure demonstrated superior performance in enucleation, morcellation, coagulation, and overall operation efficiency. Complication rates were comparable across all groups. BipoLEP, while less efficient in enucleation than some HoLEP settings, proved effective and safe. In addition, the Moses technology may offer enhanced bleeding control.
目的:本研究评估采用不同钬激光(HoLEP)设置和/或双极装置(BipoLEP)经尿道前列腺增生(BPH)患者的手术效果。设计:本研究为回顾性研究。方法:回顾性分析手术治疗的前列腺增生患者158例,按方法分为:BipoLEP(28例)、短脉冲HoLEP(26例)、长脉冲低能量HoLEP(29例)、长脉冲高能量HoLEP(26例)、Moses技术HoLEP(19例)、HoLEP与BipoLEP联合(30例)。我们在术后即刻、2周和3个月分别评估了去核、碎化、凝血和总体手术效率以及并发症。结果:HoLEP-LP/LE组整体手术效率最高(p p p p > 0.05)。结论:HoLEP-LP/LE手术在去核、粉碎、凝血和整体手术效率方面表现优异。所有组的并发症发生率具有可比性。虽然BipoLEP在去核方面的效率低于一些HoLEP设置,但被证明是有效和安全的。此外,Moses技术可以提供更好的出血控制。
期刊介绍:
Therapeutic Advances in Urology delivers the highest quality peer-reviewed articles, reviews, and scholarly comment on pioneering efforts and innovative studies across all areas of urology.
The journal has a strong clinical and pharmacological focus and is aimed at clinicians and researchers in urology, providing a forum in print and online for publishing the highest quality articles in this area. The editors welcome articles of current interest across all areas of urology, including treatment of urological disorders, with a focus on emerging pharmacological therapies.